Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032185	p-jcvnh	— (—)	137	895	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

116

75.22

197.77

7.5

1.0

—

L04AA Selective immunosuppressants

82.62

154.40

7.6

3.2

—

Renal failure

55.83

151.35

8.3

1.4

—

Azathioprine

59.96

148.75

8.4

6.0

—

All chronic kidney diseases

103

45.74

145.08

8.3

1.2

—

Hypoplasia of dental enamel

64.16

125.46

9.1

7.1

—

Molar incisor enamel hypoplasia

44.72

123.14

9.2

8.2

—

Hypoplasia of dental enamel , including avohilmo

43.88

119.91

9.0

8.7

—

ILD medications: prednisolone, methylprednisolone, prednisone

116

46.10

119.75

7.4

1.0

—

ILD medications

118

45.47

118.29

7.4

1.0

—

Second line medication for Crohn's disease

22.08

116.86

8.1

3.4

—

L04AX Other immunosuppressants

22.41

116.22

8.2

3.5

—

All kidney diseases

108

25.86

115.41

8.0

1.1

—

First line medication for Crohn's disease

116

41.64

114.52

7.4

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

102

30.72

108.73

7.6

1.2

—

Renal tubulo-interstitial diseases

22.46

107.38

7.8

2.9

—

L04AD Calcineurin inhibitors

107

218.89

103.98

8.0

2.4

—

Glomerular diseases

39.67

103.30

8.1

6.4

—

Glomerulonephritis

50.64

95.19

8.5

—

Fever of other and unknown origin

34.69

90.58

5.5

5.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

18.62

87.95

8.0

3.5

—

Chronic kidney disease

129.89

86.61

8.6

1.6

—

Antihypertensive medication - note that there are other indications

24.18

83.46

8.0

2.4

—

Hypertensive diseases (excluding secondary)

23.90

76.67

8.5

3.6

—

Intestinal infectious diseases

14.50

72.34

7.6

3.3

—

Viral and other specified intestinal infections

24.26

71.93

9.0

4.3

—

Inflammatory bowel disease treatment related agents

13.73

69.68

7.6

3.7

—

Other problems related to primary support group, including family circumstances

20.39

69.49

9.2

7.8

—

Acute tubulo-interstitial nephritis

20.57

65.78

7.8

2.9

—

Viral and other specified intestinal infections, including avohilmo

19.30

65.00

8.9

3.9

—

Cardiovascular diseases (excluding rheumatic etc)

15.15

64.81

8.1

5.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

15.42

63.95

8.8

6.6

—

Persons encountering health services for specific procedures and health care

12.38

63.42

7.3

4.9

—

Hypertensive diseases

14.47

62.94

8.5

2.7

—

Hypertension

14.47

62.93

8.5

2.7

—

Viral infections characterized by skin and mucous membrane lesions

11.55

58.33

7.1

6.9

—

Genitourinary diseases

24.75

57.79

9.4

1.1

—

Molar incisor enamel hypoplasia, with caries

84.46

56.33

8.9

9.4

—

Cardiovascular diseases

13.82

56.23

8.0

4.8

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

50.94

8.7

0.0

—

Excessive attrition of teeth

9.91

50.57

9.2

3.9

—

Gingival hyperplasia

72.56

49.40

9.5

7.0

—

Septicaemia

12.34

48.13

8.2

6.0

—

Explicit Sepsis

12.32

48.07

8.2

5.9

—

Explicit Sepsis, including avohilmo

12.27

47.81

8.2

5.9

—

GASTRO-related operations

27.10

46.23

6.9

3.6

—

Any gastric operation

27.10

46.23

6.9

3.6

—

Other septicaemia

12.78

46.06

7.7

5.8

—

Other septicaemia, including avohilmo

12.72

45.81

7.7

5.8

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

11.05

45.48

6.7

3.5

—

Nephrotic syndrome

66.43

44.50

8.8

10.1

—

Other bacterial diseases

8.16

42.59

7.6

5.3

—

Congenital malformations of the urinary system

15.01

41.70

9.1

7.9

—

Congenital malformations of the urinary system, including avohilmo

15.00

41.69

9.1

7.9

—

Other bacterial diseases, including avohilmo

7.51

39.96

7.6

5.6

—

Erosion of teeth , including avohilmo

11.79

39.38

8.5

5.2

—

Other dialysis

74.18

38.18

9.5

7.2

—

Acute upper respiratory infections of multiple and unspecified sites

10.94

37.88

6.7

3.1

—

Extracorporeal dialysis

55.97

37.42

7.6

6.9

—

All influenza

11.96

36.73

7.1

—

Bacterial infection, other or unspecified

11.54

36.29

5.5

5.0

—

Certain infectious and parasitic diseases

19.21

35.87

6.2

2.2

—

Dental caries

50.84

35.35

7.0

1.5

—

12.49

34.64

6.5

2.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

12.49

34.64

6.5

2.2

—

Other viral diseases

7.82

34.26

8.9

7.0

—

Bacterial infection, other or unspecified, including avohilmo

10.13

33.72

5.6

5.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

6.66

33.61

6.5

6.2

—

Other viral diseases, including avohilmo

7.00

31.71

8.5

6.5

—

Intestinal infectious diseases, including avohilmo, including avohilmo

8.51

31.70

6.1

3.5

—

Acute suppurative otitis media

9.87

31.21

8.1

6.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6.33

31.10

6.5

6.7

—

Other viral diseases, not elsewhere classified

8.20

31.05

8.9

7.8

—

Influenza and pneumonia

6.27

31.01

6.9

5.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

7.62

30.30

8.8

8.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.61

30.24

8.8

8.3

—

General symptoms and signs

12.53

29.90

4.6

4.7

—

Congenital malformations, deformations and chromosomal abnormalities

6.93

29.58

6.8

5.9

—

Other viral diseases, not elsewhere classified, including avohilmo

7.26

29.37

8.5

7.3

—

Aplastic and other anaemias

11.27

29.17

6.7

4.9

—

Viral warts, including avohilmo

10.03

28.24

7.3

6.6

—

Anomalies of dental arch relationship, including avohilmo

10.36

27.45

7.9

6.4

—

Disorders of other endocrine glands

6.43

27.42

8.4

6.9

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

6.61

27.32

6.7

5.9

—

Otitis media, unspecified

10.62

27.25

6.9

7.6

—

Nausea and vomiting

8.18

26.97

8.9

7.9

—

Crowding of teeth, including avohilmo

8.13

26.88

7.8

9.1

—

Suppurative and unspecified otitis media

8.87

26.67

7.4

6.1

—

Pneumonia, organism unspecified

6.16

26.65

7.2

5.9

—

Anaemias

47.56

26.57

7.8

8.2

—

Nonsuppurative otitis media

9.24

26.40

5.9

6.6

—

Disorders resulting from impaired renal tubular function

51.00

25.31

8.5

5.7

—

Other reaction to severe stress, and adjustment disorders

9.38

25.23

4.9

4.7

—

Other disorders of kidney and ureter

35.74

25.17

8.4

7.0

—

Caries of dentine

42.76

25.04

5.6

1.6

—

Bronchitis

8.06

24.98

5.1

2.5

—

Bacterial Sepsis

10.34

24.52

6.4

5.3

—

Care involving use of rehabilitation procedures

8.46

23.74

6.7

5.1

—

Diseases of middle ear and mastoid

7.20

23.08

5.8

5.2

—

General examination and investigation of persons without complaint and reported diagnosis

13.18

23.01

7.2

1.5

—

Any reimbursement code in KELA

36.13

22.56

5.9

1.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.91

22.29

7.2

6.2

—

Pneumonias (Asthma/COPD co-morbidities)

4.94

22.28

7.2

6.1

—

Acute renal failure

52.10

22.06

6.3

1.8

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

5.48

21.91

8.0

6.9

—

Implicit Sepsis

6.66

21.20

5.7

5.3

—

Deep bite

6.28

21.06

8.6

8.8

—

Provisional assignment of new diseases of uncertain etiology

6.49

20.99

6.4

5.3

—

Codes for special purposes

6.49

20.99

6.4

5.3

—

Nonsuppurative otitis media, including avohilmo

7.45

20.42

6.1

5.9

—

Acute upper respiratory infections

6.87

20.17

5.9

2.9

—

All pneumoniae

4.58

20.14

7.2

6.1

—

Implicit Sepsis, including avohilmo

6.19

20.12

5.6

5.2

—

Viral warts

20.84

19.90

7.7

6.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

5.89

19.47

5.5

5.0

—

Implicit viral Sepsis

20.05

19.01

6.5

6.9

—

Viral Sepsis

20.05

19.01

6.5

6.9

—

Disorders of refraction and accommodation

5.75

18.69

8.7

7.9

—

Hypoplasia of dental enamel, prenatal , including avohilmo

26.22

18.35

11.0

10.2

—

Covid-19 confirmed case

7.81

18.23

6.5

4.6

—

6.88

17.99

5.2

2.6

—

Examination and observation for other reasons

11.29

17.81

6.5

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

5.40

17.73

5.5

5.1

—

Certain conditions originating in the perinatal period

6.15

17.39

9.4

7.1

—

Implicit viral Sepsis, including avohilmo

12.07

16.25

6.3

5.5

—

COPD/asthma/ILD related infections

7.29

15.70

5.7

2.2

—

COPD/asthma related infections

7.29

15.70

5.7

2.2

—

Symptoms and signs concerning food and fluid intake

26.28

15.55

8.8

5.4

—

Heart failure, not strict

5.69

15.37

5.2

5.3

—

Anxiety disorders, excluding more controls

5.43

14.83

5.9

4.4

—

5.24

14.49

9.6

9.1

—

Disorders of psychological development

4.97

14.25

8.2

8.8

—

Lack of expected normal physiological development

20.81

14.09

8.3

8.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

9.35

13.89

6.5

1.5

—

Crossbite

4.87

13.85

9.5

8.4

—

Other endocrine disorders

5.89

13.84

11.0

9.0

—

Caries of enamel

4.77

13.53

6.8

4.0

—

Neurotic, stress-related and somatoform disorders

4.29

13.30

6.3

4.9

—

Anxiety disorders

4.27

13.22

6.3

4.9

—

All influenza (not pneumonia)

12.14

13.06

7.0

7.5

—

Implicit bacterial Sepsis, including avohilmo

10.95

12.98

5.5

4.6

—

Headache

11.36

12.97

4.9

4.5

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

5.24

12.86

8.5

8.7

—

Implicit bacterial Sepsis

11.44

12.82

5.5

4.5

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.37

12.80

8.4

7.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.08

12.80

6.6

5.6

—

Other disorders starting during childhood or adolecense, excluding more controls

9.62

12.54

7.8

9.2

—

Other disorders of urethra and urinary system

5.17

12.53

8.3

4.4

—

Convulsions, not elsewhere classified

17.08

12.39

6.2

6.7

—

4.97

12.39

9.8

9.1

—

Certain infectious and parasitic diseases, including avohilmo

15.04

12.27

6.0

2.0

—

Speech and linguistic disorders, excluding more controls

9.06

12.13

9.8

9.0

—

Infections, IBD-co-morbidities

15.64

11.59

5.5

8.4

—

Persons encountering health services in other circumstances, wide

3.85

11.54

6.9

5.6

—

Other acute lower respiratory infections

4.01

11.49

6.8

6.7

—

Medical observation and evaluation for suspected diseases and conditions

8.26

11.35

5.8

1.5

—

Tonsillectomy and adenotomy

3.62

11.33

7.6

7.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

17.34

11.23

9.7

8.8

—

Other disorders starting during childhood or adolescence

4.55

11.00

8.5

9.2

—

Endocrine, nutritional and metabolic diseases

3.72

10.97

7.3

6.0

—

Other disorders of fluid, electrolyte and acid-base balance

9.90

10.78

7.6

4.0

—

Other bacterial intestinal infections

28.04

10.71

3.9

4.6

—

Zoster [herpes zoster]

28.03

10.71

2.6

6.4

—

Metabolic disorders

3.68

10.47

7.0

6.0

—

Speech and linguistic disorders

4.13

10.07

9.8

8.5

—

Other heart diseases

5.34

10.00

8.4

5.1

—

Short stature, not elsewhere classified

5.08

9.81

9.6

8.8

—

Other bacterial intestinal infections, including avohilmo

20.02

9.79

3.9

4.4

—

Symptoms and signs involving the digestive system and abdomen

3.42

9.61

6.8

6.4

—

Unspecified haematuria

9.67

9.41

4.7

6.5

—

Other and unspecified anaemias

7.58

9.33

5.9

4.9

—

Other anaemias

7.56

9.31

5.9

4.9

—

Other congenital malformations of the digestive system

4.88

9.22

7.3

10.5

—

Diseases of external ear

4.40

9.06

9.5

6.8

—

Other cataract

10.29

9.02

7.7

4.2

—

Other and unspecified dermatitis

4.32

8.84

7.3

5.0

—

Hypermetropia

6.80

8.81

9.1

9.3

—

Overjet

4.70

8.77

8.9

9.3

—

Acute sinusitis

6.82

8.69

4.2

3.0

—

Dermatitis

3.98

8.64

7.0

5.6

—

Certain disorders involving the immune mechanism

8.20

8.55

4.2

7.8

—

Hernia

3.37

8.42

7.5

5.8

—

Diseases of the ear and mastoid process

3.55

8.41

5.6

4.2

—

Excessive, frequent and irregular menstruation

10.68

8.40

4.1

3.6

—

Disorders of tooth development and eruption

17.65

8.34

10.8

1.7

—

Other and unspecified tonsillitis

6.93

8.26

7.6

3.7

—

Acute bronchiolitis

4.01

8.16

8.0

9.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

7.51

8.14

3.1

8.9

—

Non-Hodgkin lymphoma, all, including Hilmo

17.17

8.06

2.7

6.3

—

Other congenital malformations of the digestive system, including avohilmo

4.34

8.05

7.3

10.5

—

Immunodeficiency with predominantly antibody defects

22.21

8.02

5.4

8.2

—

Symptoms and signs involving the urinary system

3.64

7.99

5.7

6.5

—

Malaise and fatigue

9.69

7.97

3.1

5.8

—

Dentofacial anomalies [including malocclusion]

3.91

7.92

7.7

3.5

—

Distal bite

4.26

7.85

9.0

—

Congenital vesicoureteral reflux

15.68

7.79

9.3

7.3

—

Bacterial intestinal infections, IBD co-morbidities

10.78

7.78

3.9

6.4

—

Other diseases of urinary system

3.11

7.71

7.6

5.8

—

COPD differential diagnosis

6.01

7.70

5.0

1.7

—

ILD differential diagnosis

6.01

7.70

5.0

1.7

—

Excluding asthma or asthma-COPD overlap

6.01

7.70

5.0

1.7

—

Otitis externa

5.89

7.66

9.6

8.3

—

Oxycodone

10.88

7.56

1.5

—

Other medical care

8.39

7.51

2.4

4.1

—

Disorders of lens

4.91

7.48

7.4

3.1

—

Liquid cancers

6.56

7.41

3.1

8.7

—

Immunodeficiencies

13.41

7.38

5.0

7.4

—

Chronic diseases of tonsils and adenoids

2.95

7.37

7.8

6.8

—

Other diseases of hard tissues of teeth

10.36

7.36

9.6

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

9.40

7.28

11.4

10.2

—

Diseases of the eye and adnexa

3.24

7.24

5.9

7.1

—

Complications of surgical and medical care, not elsewhere classified

3.28

7.15

5.2

5.1

—

Hypo-osmolality and hyponatraemia

19.86

7.09

8.2

5.2

—

Zoster [herpes zoster], including avohilmo

6.56

7.06

3.2

3.6

—

Acute pharyngitis

7.83

7.04

6.9

4.4

—

Other pulmonary diagnosis

5.68

6.95

5.2

1.7

—

Otitis externa, unspecified

7.52

6.89

9.5

7.6

—

All anxiety disorders

3.51

6.86

5.9

5.0

—

Cough

3.70

6.80

7.2

6.6

—

Exclusions for E4_PCOS_BROAD

3.78

6.78

8.1

9.2

—

Pain, not elsewhere classified

10.01

6.52

3.8

5.8

—

Liquid cancers, including Hilmo

5.47

6.47

3.1

8.1

—

Hernia of abdominal wall

5.67

6.43

6.8

4.4

—

Inguinal hernia

3.65

6.34

8.2

6.0

—

Persons with potential health hazards related to communicable diseases

3.03

6.33

8.4

7.3

—

Nonhereditary hypogammaglobulinemia

+∞

6.26

4.2

0.0

—

Other strabismus

3.82

6.21

8.2

8.7

—

Bacterial pneumoniae

5.53

6.18

5.3

5.6

—

Varicella [chickenpox]

12.56

6.08

5.2

9.3

—

Agranulocytosis

12.52

6.07

8.4

6.6

—

Umbilical hernia

8.58

6.04

7.1

3.7

—

Other diseases of blood and blood-forming organs, wide

6.67

6.02

7.2

6.5

—

Complications of medical and surgical care

3.52

6.01

5.7

4.6

—

Bacterial pneumonia (organism specified)

3.79

6.00

5.3

6.1

—

Hyperkinetic disorders, excluding more controls

5.54

5.92

9.7

7.6

—

Neoplasms

2.66

5.89

6.7

7.5

—

Autoimmune diseases related-to ILD

3.02

5.84

4.0

5.8

—

Oedema, not elsewhere classified

14.66

5.82

8.0

4.3

—

Bacterial pneumonia, not elsewhere classified

5.40

5.76

5.1

5.7

—

Specific development disorders of scholastic skills

3.94

5.71

6.5

8.7

—

Respiratory and cardiovascular disorders specific to the perinatal period

3.22

5.69

10.9

9.0

—

Acute bronchitis

3.45

5.68

7.6

7.5

—

Irregular menses

5.46

5.64

3.7

2.7

—

Infections of the skin and subcutaneous tissue

2.77

5.63

6.7

6.8

—

Other anxiety disorders

3.65

5.60

3.7

4.7

—

Emotional disorders starting during childhood or adolecense, excluding more controls

6.66

5.59

5.7

8.9

—

Hypokalaemia

12.87

5.57

7.3

5.9

—

Delayed milestone in childhood

3.33

5.44

8.5

10.2

—

Polycystic kidney disease

16.12

5.41

7.3

7.0

—

Disorders of parathyroid gland

15.82

5.37

3.1

2.2

—

Tooth eruption problems

3.12

5.37

7.6

7.5

—

Urinary track infection

4.26

5.30

5.6

5.3

—

Asthma (only as main-diagnosis), excluding more controls

5.92

5.27

4.1

1.7

—

Anti-inflammatory and antirheumatic products, non-steroids

0.00

5.25

0.0

6.8

—

Other demyelinating diseases of the central nervous system

+∞

5.21

1.0

0.0

—

MS-disease / Multiple Sclerosis

+∞

5.21

1.2

0.0

—

Ascites

+∞

5.21

6.2

0.0

—

Polycystic ovarian syndrome, consortium definition

4.17

5.16

3.7

2.7

—

Any mental disorder

2.86

5.15

6.2

5.3

—

Asthma, unspecified (mode), excluding more controls

7.15

5.13

6.7

1.8

—

Asthma (only as main-diagnosis)

5.59

5.09

4.1

1.7

—

Disturbance of activity and attention

3.32

5.08

9.7

7.7

—

Enlarged lymph nodes

13.34

5.07

2.8

6.0

—

Noninflammatory disorders of female genital tract

5.79

5.07

5.2

5.5

—

Covid-19 suspected case

5.66

5.05

7.2

5.1

—

Non-allergic asthma (mode), excluding more controls

13.22

5.05

7.4

2.5

—

Non-allergic asthma (mode)

13.22

5.05

7.4

2.5

—

Invasive ventilation

10.02

5.02

14.1

7.8

—

Melanocytic naevi of trunk

10.01

5.02

10.0

6.8

—

Mycoses

4.69

4.98

5.7

6.4

—

Used for control exclusion in common control thyroid runs

2.34

4.97

5.5

7.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.82

4.94

4.1

6.5

—

Asthma, unspecified (mode)

6.66

4.93

6.7

1.8

—

Open bite

3.68

4.92

9.3

8.8

—

Childhood asthma (age<16)

8.69

4.91

6.4

2.0

—

Heart failure and antihypertensive medication

7.94

4.90

4.7

1.0

—

Acute laryngitis and tracheitis

6.78

4.88

9.7

4.9

—

Anxiety (asthma-related co-morbidities)

2.81

4.86

5.9

5.5

—

Candidiasis

7.70

4.84

4.0

7.8

—

Abdominal and pelvic pain

2.59

4.83

7.3

6.4

—

Diseases of the respiratory system

5.37

4.82

5.8

1.7

—

Asthma

5.16

4.72

4.1

1.7

—

Psychiatric diseases

2.76

4.70

6.4

5.3

—

Motor disorders, excluding more controls

5.71

4.67

8.9

10.1

—

Melanocytic naevi

4.29

4.61

9.3

5.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.50

4.60

5.5

4.5

—

Congenital malformations and deformations of the musculoskeletal system

3.09

4.58

7.6

9.6

—

Need for other prophylactic measures

8.21

4.56

10.2

9.1

—

Strabismus

2.96

4.52

7.8

8.7

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.96

4.49

7.7

9.3

—

Varicella [chickenpox], including avohilmo

6.68

4.46

5.2

10.5

—

Herpesviral [herpes simplex] infections, including avohilmo

6.67

4.46

6.0

3.7

—

Asthma, excluding more controls

5.13

4.42

3.5

1.7

—

Mandibular retrognathia

4.38

4.42

8.8

8.4

—

Any event in cancer register

2.65

4.29

3.0

7.1

—

Dysphagia

11.67

4.27

4.4

8.5

—

Nutritional anaemias

3.33

4.25

9.3

5.2

—

Childhood asthma (age<16), excluding more controls

7.82

4.24

5.7

2.0

—

Specific development disorders of speech and language

3.16

4.19

11.8

9.0

—

Systemic connective tissue disorders

5.24

4.13

3.6

5.4

—

Other diseases of lip and oral mucosa

4.00

4.09

6.0

5.5

—

Asthma-related pneumonia

2.97

4.08

6.8

7.8

—

Contraceptive management

4.26

4.08

4.1

1.9

—

Other disorders of adrenal gland

8.03

4.06

7.4

6.8

—

Volume depletion

8.01

4.06

8.9

6.3

—

Persons encountering health services for examination and investigation

5.02

4.05

6.4

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

3.94

4.02

11.8

9.7

—

Asthma-related pneumonia or sepsis

2.92

3.97

6.8

8.0

—

Asthma, hospital admissions 3, pneumonia

2.92

3.97

6.8

8.0

—

Persons encountering health services in other circumstances

3.30

3.96

6.2

5.9

—

Gingivitis and periodontal diseases

2.41

3.88

5.6

7.3

—

Asthma (mode)

4.55

3.81

3.8

1.7

—

Symptoms and signs involving the circulatory and respiratory systems

2.31

3.79

6.1

5.7

—

Continuous positive airway pressure

4.83

3.78

11.5

8.6

—

Disorders of skin appendages

2.66

3.77

7.2

5.0

—

Explicit bacterial Sepsis

8.76

3.77

8.9

9.0

—

Explicit bacterial Sepsis, including avohilmo

8.76

3.77

8.9

9.0

—

Haemolytic anaemias

12.04

3.76

9.2

10.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

12.01

3.76

2.7

8.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

12.01

3.76

4.5

5.6

—

Other CVD

12.00

3.76

4.7

6.4

—

Undetermined asthma

12.00

3.76

8.5

1.4

—

Gout, FINNGEN

8.69

3.75

4.0

1.5

—

Chronic periodontitis, including avohilmo

3.01

3.73

1.6

2.9

—

Periodontitis

3.01

3.72

1.6

2.9

—

Visual disturbances and blindness

2.64

3.71

5.6

6.9

—

Dental caries, including avohilmo

3.28

3.69

7.3

5.4

—

Neurological diseases, wide definition

3.43

3.65

5.9

8.3

—

Iron deficiency anaemia

3.52

3.61

9.6

5.5

—

Amblyopia ex anopsia

4.02

3.59

7.5

9.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

9.44

3.58

2.1

3.8

—

Malignant neoplasm

2.49

3.56

2.9

7.3

—

Other noninfective gastroenteritis and colitis

2.94

3.56

8.7

8.4

—

Malignant neoplasm

2.49

3.56

2.9

7.3

—

Other heart diseases, wide

2.13

3.55

8.0

6.2

—

Hypopituitarism

3.88

3.48

9.2

8.7

—

Tooth agenesis EXCLUDE clefts and syndromes

3.88

3.48

7.5

8.6

—

Oral corticosteroids

3.02

3.45

2.5

3.1

—

2.35

3.41

6.3

7.2

—

Diseases of pulp and periapical tissues and dental caries

3.20

3.37

7.7

5.0

—

Diseases of the skin and subcutaneous tissue

2.33

3.37

6.7

5.3

—

Congenital deformities of feet

7.04

3.36

4.7

8.4

—

Speech therapy

5.00

3.36

6.0

6.2

—

Emotional disorders and disorders of social functioning with onset specific to childhood

3.11

3.36

5.7

8.4

—

Paralytic ileus and intestinal obstruction

7.00

3.36

2.7

5.1

—

Congenital deformities of feet, including avohilmo

5.74

3.34

5.3

7.7

—

Opioids

2.82

3.34

2.4

3.0

—

Astigmatism

3.93

3.28

11.1

9.1

—

Hyperkinetic disorders

2.47

3.28

9.7

7.7

—

Heart failure,strict

3.81

3.25

4.4

—

Heart failure, strict

3.79

3.23

4.4

—

Visual disturbances

2.58

3.20

5.8

6.9

—

Gout

6.67

3.18

4.0

1.4

—

Perforation of tympanic membrane

6.37

3.18

6.4

8.3

—

Other skin changes

6.37

3.18

3.3

7.6

—

Abnormalities of breathing

2.23

3.09

5.5

5.8

—

Other disorders of skin and subcutaneous tissue

2.56

3.06

5.4

—

Bacterial, viral and other infectious agents

7.51

3.05

6.8

7.8

—

Other diseases of intestine

7.51

3.05

3.2

4.6

—

Diagnoses used for exclusion with ILD

7.50

3.05

4.5

3.9

—

Non-ischemic cardiomyopathy

5.29

3.05

5.9

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.16

3.04

4.8

4.5

—

Dermatitis and eczema

2.02

3.03

5.4

6.0

—

All-cause Heart Failure

3.82

3.03

4.5

4.7

—

Procreative management

2.35

3.03

7.5

8.6

—

Malignant neoplasm of digestive organs, including Hilmo

6.43

3.02

4.6

3.9

—

Other diseases of pericardium

10.02

2.98

6.2

8.2

—

Chronic iridocyclitis

10.02

2.98

1.0

8.0

—

Cholangitis (primary sclerosing, PSC)

10.01

2.98

4.6

7.8

—

Other contact dermatitis

10.01

2.98

5.2

7.2

—

Noninfective enteritis and colitis

2.34

2.96

7.1

6.9

—

Open wound of wrist and hand

0.00

2.96

0.0

5.4

—

Persons encountering health services in circumstances related to reproduction

2.08

2.95

6.2

7.5

—

Intestinal stricture

4.71

2.91

3.6

5.4

—

Intermittent heterotropia

3.44

2.89

8.8

9.3

—

Disorders of sclera, cornea, iris and ciliary body

2.69

2.88

2.7

4.8

—

Syncope and collapse

7.15

2.88

1.0

3.4

—

Unspecified acute lower respiratory infection

4.09

2.88

4.8

7.0

—

Asthma, hospital admission 2, infections

2.17

2.87

6.3

6.9

—

Asthma-related infections

2.17

2.87

6.3

6.9

—

Anterior Iridocyclitis

5.39

2.86

1.6

5.5

—

Inflammatory diseases of the central nervous system

6.67

2.86

6.8

5.4

—

Malignant neoplasm of skin, including Hilmo

5.86

2.81

2.1

2.8

—

Disorders in reading

4.48

2.80

6.5

8.9

—

Congenital malformations of the circulatory system

2.33

2.78

8.1

9.1

—

Recurrent aphthous stomatitis , including avohilmo

3.92

2.77

5.8

7.1

—

Specific developmental disorder of motor function

3.11

2.76

8.9

9.8

—

Streptococcal septicaemia

8.34

2.75

12.0

9.8

—

Dermatophytosis

8.34

2.75

3.8

6.3

—

Gout, idiopatic and unspecified

8.34

2.75

5.2

1.7

—

Gastroduodenal ulcer

8.31

2.74

1.8

3.2

—

Diseases of the digestive system

2.52

2.73

4.1

6.5

—

Impacted cerumen

5.01

2.72

10.7

9.0

—

Other diseases of intestines

1.89

2.72

4.9

7.4

—

Diseases of the musculoskeletal system and connective tissue

2.04

2.72

6.5

8.2

—

Missing teeth due to accident, extraction or parodontitis

3.27

2.71

2.5

3.2

—

Rash and other nonspecific skin eruption

6.01

2.70

7.0

10.1

—

Sequelae with surgical and medical care as external cause

6.00

2.69

4.7

6.1

—

Hypertensive Heart Disease

6.50

2.68

5.3

2.4

—

Ovarian cyst

5.72

2.68

2.7

2.4

—

Mental retardation, excluding more controls

3.79

2.67

7.2

9.8

—

Respiratory distress of newborn

2.72

2.64

9.0

9.3

—

Benign neoplasms

2.05

2.63

6.9

5.3

—

Hypertensive heart and/or renal disease

5.11

2.62

5.4

2.0

—

Malnutrition

4.70

2.60

7.9

10.5

—

Other disorders of bone

4.67

2.59

6.7

5.4

—

Other functional intestinal disorders

2.21

2.59

5.2

8.3

—

Disturbances of skin sensation

4.00

2.56

3.1

3.3

—

Solid cancers

2.43

2.56

3.5

6.1

—

Phobic anxiety disorders

3.99

2.56

5.8

6.0

—

Cystitis

2.19

2.55

6.5

5.7

—

Streptococcal septicaemia, including avohilmo

7.15

2.55

12.0

8.6

—

Pulmonary embolism

7.14

2.55

3.0

1.6

—

Pulmonary heart disease

7.14

2.55

3.0

1.6

—

Congenital malformations of heart and great arteries

2.29

2.54

8.5

9.3

—

Motor disorders

2.74

2.52

8.9

10.6

—

Bleeding

2.13

2.50

5.2

7.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.90

2.49

4.1

7.4

—

Urticaria and erythema

2.32

2.47

7.0

7.7

—

Pain in limb

1.97

2.47

5.0

6.8

—

Personality disorders, excluding more controls

4.37

2.46

2.0

1.9

—

Autoimmune diseases excluding thyroid diseases

1.89

2.46

4.1

7.4

—

Urticaria

2.38

2.45

7.4

7.3

—

Other neurological diseases

2.52

2.44

3.2

4.8

—

Fitting and adjustment of other devices

5.28

2.44

7.0

2.6

—

Candidiasis, including avohilmo

3.13

2.43

4.0

5.5

—

Malignant neoplasm, including Hilmo

2.10

2.42

3.0

7.3

—

Malignant neoplasm, wide definition

2.10

2.42

3.0

7.3

—

Conductive hearing loss, unspecified

5.01

2.40

6.5

7.9

—

Bacterial, viral and other infectious agents, including avohilmo

5.01

2.40

6.8

9.3

—

Viral pneumonia

5.00

2.40

8.2

6.2

—

In situ neoplasms

5.00

2.40

2.0

1.0

—

Embedded and impacted teeth

2.26

2.40

8.0

6.2

—

Sequelae of external causes of morbidity and mortality

3.64

2.36

3.8

4.6

—

Autoimmune diseases

1.82

2.34

4.6

7.4

—

Cerebrovascular diseases (FINNGEN)

5.26

2.33

4.0

1.5

—

Emotional disorders starting during childhood or adolescence

2.48

2.31

5.7

9.7

—

Basal cell carcinoma

6.82

2.31

1.0

3.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

6.78

2.30

1.0

3.8

—

Basal cell carcinoma, including Hilmo

6.77

2.29

1.0

3.8

—

Disease of hard tissues of teeth, NOS

4.58

2.27

7.0

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

4.62

2.27

2.7

4.5

—

Diseases of oral cavity, salivary glands and jaws

4.51

2.24

8.1

1.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

5.97

2.24

4.0

2.4

—

Impacted teeth

2.30

2.23

8.7

6.2

—

Stomatitis and related lesions

3.11

2.22

5.8

6.3

—

Other diseases of the digestive system

3.10

2.22

6.1

6.9

—

GI-bleeding

3.10

2.22

6.1

6.9

—

Ventral hernia

5.56

2.21

7.0

2.6

—

Orchitis and epididymitis

5.56

2.21

3.4

6.3

—

Congenital malformations of the respiratory system

3.71

2.15

5.1

10.4

—

Congenital malformations of the respiratory system, including avohilmo

3.71

2.15

5.1

10.4

—

Other metabolic disorders

4.29

2.15

8.8

5.5

—

Acne

2.77

2.12

9.3

5.9

—

Tramadol

3.18

2.12

1.8

2.2

—

Injuries to the wrist and hand

119

0.39

2.09

2.1

6.5

—

Mood disorders, excluding more controls

2.32

2.09

2.5

3.8

—

Disorders of speech understanding and production

2.58

2.08

12.6

9.3

—

Congenital stenosis of pulmonary valve

5.07

2.08

12.2

9.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

5.02

2.07

1.8

9.9

—

Other disorders involving the immune mechanism, not elsewhere classified

5.01

2.07

1.8

9.9

—

Polyneuropathies and other disorders of the peripheral nervous system

5.00

2.07

2.0

7.5

—

Obsessive-compulsive disorder

5.00

2.07

11.4

7.2

—

Pain (limb, back, neck, head abdominally)

1.95

2.06

5.9

8.1

—

Hyperlipidaemia, other/unspecified

4.15

2.06

2.8

1.3

—

Mild mental retardation

3.52

2.05

7.0

7.6

—

Congenital malformations of pulmonary and tricuspid valves

4.06

2.05

10.3

10.2

—

Cardiac murmurs and other cardiac sounds

2.67

2.03

13.8

7.8

—

Osteopathies and chondropathies

2.24

2.01

4.9

6.2

—

Atopic dermatitis, strict definition with reimbursement

2.11

2.00

7.0

7.2

—

Mouth breathing

2.05

1.99

9.5

7.3

—

Iridocyclitis

3.33

1.96

1.6

5.0

—

Presence of other functional implants

4.11

1.96

3.5

1.4

—

Haemorrhage from respiratory passages

2.60

1.94

3.6

6.2

—

Other retinal disorders

2.53

1.94

3.0

3.8

—

Conotruncal defects

2.99

1.94

9.1

—

Viral pneumonia (unknown virus, not influenza)

4.55

1.94

7.8

7.9

—

Hypertension, essential

2.83

1.94

2.7

2.2

—

Disorders of puberty, all

2.98

1.94

5.8

7.7

—

Disorders of puberty

3.77

1.94

6.0

6.7

—

Other arthritis (FG)

2.73

1.93

6.3

5.4

—

Malignant neoplasm of digestive organs

4.78

1.92

6.0

3.9

—

Statin medication

2.22

1.90

4.8

3.3

—

Conjunctivitis (acute, non atopic), including avohilmo

1.78

1.90

7.1

6.1

—

Other diseases of upper respiratory tract

1.78

1.89

6.0

6.7

—

Any death

2.74

1.85

1.1

4.1

—

Solid cancers, including Hilmo

2.12

1.84

3.6

6.8

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.55

1.84

4.7

7.8

—

Cardiovascular disorders originating in the perinatal period

4.27

1.83

9.6

9.3

—

Slow fetal growth and fetal malnutrition

3.57

1.83

7.0

8.4

—

Complications of procedures, not elsewhere classified

2.17

1.83

4.7

4.6

—

DVT of lower extremities and pulmonary embolism

4.15

1.81

3.0

1.3

—

Polyarthropathies

2.02

1.80

4.9

6.1

—

Personality disorders

3.04

1.79

2.0

2.7

—

Other disorders of lacrimal gland

3.04

1.79

1.9

5.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.95

1.79

3.4

7.4

—

Coagulation defects, purpura and other haemorrhagic conditions

2.76

1.79

9.0

8.3

—

Diabetic retinopathy

3.72

1.78

1.7

1.6

—

Chronic sinusitis

2.76

1.78

2.5

3.5

—

Menorrhagia

4.65

1.77

4.4

2.7

—

Isolated growth hormone deficiency

2.97

1.73

8.3

10.8

—

Malignant neoplasm of skin

4.23

1.73

1.0

2.8

—

Noninfectious colitis NAS

2.92

1.72

4.1

7.2

—

Conductive and sensorineural hearing loss

2.00

1.68

8.4

5.2

—

Chronic periodontitis, complicated

2.84

1.67

2.3

1.6

—

Cellulitis

2.50

1.66

7.0

8.1

—

Impetigo

2.81

1.65

9.3

8.5

—

Mixed specific developmental disorders

2.27

1.63

8.2

9.5

—

Other and unspecified local infections of skin and subcutaneous tissue

3.57

1.61

3.6

7.5

—

Other local infections of skin and subcutaneous tissue

3.57

1.61

3.6

7.5

—

Chondropathies

3.57

1.61

7.8

5.5

—

Cardiomyopathy

3.57

1.61

5.2

7.7

—

Diabetic retinopathy, excluding more controls

3.36

1.61

1.7

1.6

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.14

1.60

8.8

8.0

—

Scissor bite

2.23

1.60

10.2

8.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.14

1.60

1.3

—

Other disorders of ear

1.75

1.58

8.0

6.3

—

Other disorders of eye and adnexa

2.69

1.58

3.6

6.7

—

Fracture of skull and facial bones

2.69

1.58

8.1

6.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.70

1.56

5.6

1.1

—

Other diseases of pleura

2.48

1.55

3.4

5.0

—

Sleep disorders (combined)

0.46

1.55

5.3

5.6

—

Fracture of femur

3.47

1.55

4.6

6.7

—

Atopic dermatitis

1.80

1.55

6.9

6.4

—

Other disorders originating in the perinatal period

2.45

1.54

9.1

9.4

—

Degeneration of macula and posterior pole

3.51

1.53

2.6

3.1

—

Diseases of oesophagus, stomach and duodenum

1.77

1.53

2.5

6.5

—

Disorders of gallbladder, biliary tract and pancreas

1.98

1.53

4.5

3.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.76

1.52

2.3

2.5

—

Panic disorder

3.33

1.52

4.2

3.9

—

Conjunctivitis (acute, non atopic)

1.96

1.51

6.6

8.4

—

Right ventricular outflow tract obstruction

2.89

1.51

10.3

8.5

—

STROKE

2.52

1.50

1.9

3.8

—

Non-invasive ventilation

2.88

1.49

8.5

5.9

—

Transient ischemic attack

3.32

1.47

1.0

2.1

—

Injuries to the knee and lower leg

111

0.49

1.45

5.8

6.2

—

Other disorders of penis

2.50

1.45

9.4

8.9

—

Non-rheumatic valve diseases

2.18

1.44

9.6

6.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.13

1.44

2.2

3.3

—

Other arthrosis

2.87

1.43

2.7

1.9

—

Myopia

2.73

1.43

7.0

6.3

—

Specific personality disorders

2.73

1.43

2.2

2.6

—

Other benign neoplasms of skin

2.73

1.43

3.7

4.6

—

Adverse effects, not elsewhere classified

2.31

1.42

8.7

8.0

—

Single spontaneous delivery

0.00

1.42

0.0

3.0

—

Delivery

0.00

1.42

0.0

2.9

—

Erysipelas

2.72

1.40

2.5

1.7

—

Fall on and from stairs and steps

2.41

1.39

5.7

—

Erysipelas, including avohilmo

2.47

1.38

3.0

2.0

—

Diseases of pulp and periapical tissues, including avohilmo

104

0.50

1.37

3.9

6.9

—

Cerebral palsy and other paralytic syndromes

2.94

1.36

5.6

7.2

—

Calculus of kidney and ureter

2.94

1.36

5.6

5.2

—

Asthma, hospital admissions , main diagnosis only

110

1.66

1.35

5.8

6.5

—

Excessive earwax

1.84

1.34

9.5

5.8

—

Sensorineural hearing loss

1.97

1.33

8.7

4.5

—

Codeine

2.21

1.32

2.0

1.8

—

Atopic dermatitis, strict definition

1.78

1.32

7.0

7.5

—

Ulcerative colitis, NAS

2.50

1.30

7.0

6.1

—

Disorders of choroid and retina

2.00

1.29

2.8

4.3

—

Other and unspecified iron deficiency

2.35

1.29

13.4

6.1

—

Disorders of optic nerve and visual pathways

2.78

1.28

4.2

7.9

—

Urolithiasis

2.78

1.28

5.6

—

Diseases of arteries, arterioles and capillaries

2.35

1.28

2.0

3.6

—

Other and unspecified effects of external causes

2.00

1.27

8.4

7.1

—

Other soft tissue disorders, not elsewhere classified

1.58

1.25

5.1

6.8

—

Cutaneous abscess, furuncle and carbuncle

2.22

1.24

6.1

6.2

—

Keratitis

2.22

1.24

3.5

5.5

—

Delivery, wide proxy

0.00

1.22

0.0

3.1

—

Exposure to other specified factors

122

0.49

1.21

7.6

6.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.72

1.20

2.4

5.3

—

Contact with and exposure to communicable diseases

1.79

1.19

7.4

7.7

—

Other and unspecified urticaria

2.11

1.18

9.3

8.0

—

Dizziness and giddiness

1.90

1.17

1.9

4.8

—

Benzodiazepine use

1.77

1.17

1.9

3.7

—

Venous thromboembolism

2.53

1.16

3.0

2.0

—

Weight loss

2.50

1.15

11.4

8.6

—

Other disorders of glucose regulation and pancreatic internal secretion

2.50

1.15

4.6

9.2

—

Extrapyramidal and movement disorders

2.50

1.15

2.2

4.3

—

Other diseases of anus and rectum

2.49

1.14

8.6

5.6

—

Nerve, nerve root and plexus disorders

1.86

1.13

1.8

4.1

—

Congenital malformations of eye, ear, face and neck

2.34

1.12

4.6

10.2

—

Other specified/unspecified arthritis

2.33

1.12

6.7

5.6

—

Acne vulgaris

2.33

1.12

9.7

5.9

—

Recurrent or chronic depression

2.31

1.11

1.3

2.8

—

Heart failure and coronary heart disease

2.50

1.10

3.0

4.6

—

Abnormal findings on examination of blood, without diagnosis

1.97

1.10

4.5

6.0

—

Senile cataract

2.53

1.09

1.0

1.5

—

Heterophoria

2.38

1.09

8.2

7.2

—

Undescended testicle

2.39

1.09

9.4

9.2

—

Disorders of adult personality and behaviour

2.19

1.08

2.6

3.3

—

Childhood allergy (age < 16)

1.67

1.07

6.1

8.0

—

Diabetes mellitus in pregnancy

2.44

1.06

1.0

2.5

—

Pain in throat and chest

1.69

1.06

3.8

5.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.60

1.05

6.4

7.6

—

Finngen Rheumatological endpoints

1.61

1.05

5.9

6.0

—

Abnormal serum enzyme levels

2.30

1.04

5.4

5.6

—

Bacterial sepsis of newborn

2.30

1.04

11.8

7.5

—

Other specified congenital malformation syndromes affecting multiple systems

2.28

1.03

4.6

10.4

—

Abnormalities of gait and mobility

2.27

1.03

3.8

7.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.96

1.03

8.2

5.4

—

Reimbursement for rheumatic diseases

1.82

1.00

4.2

6.4

—

Redundant prepuce, phimosis and paraphimosis

1.97

0.98

4.0

7.1

—

Chronic suppurative otitis media, including avohilmo

2.18

0.98

6.0

8.1

—

Exclusion endpoint for clefts

2.18

0.98

4.6

10.1

—

Disorders of lacrimal system

1.91

0.95

1.9

5.4

—

Hypothyroidism, strict autoimmune

1.79

0.94

3.4

4.6

—

Embedded teeth, including avohilmo

2.22

0.93

8.3

6.1

—

Other joint disorders

0.57

0.93

6.3

6.2

—

Valvular heart disease excluding rheumatic fever

1.78

0.91

9.6

6.5

—

Disorders of synovium and tendon

1.94

0.89

4.9

4.3

—

Acne, including avohilmo

1.70

0.88

8.4

5.8

—

Inflammatory bowel disease

1.86

0.87

5.5

5.7

—

Other maternal disorders predominantly related to pregnancy

1.98

0.84

1.2

2.4

—

Diseases of male genital organs

1.54

0.84

7.0

7.7

—

Mycoses, including avohilmo

1.50

0.83

5.5

5.8

—

Allergic colitis

1.88

0.81

13.0

8.9

—

Ulcerative colitis

1.88

0.81

7.0

5.6

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.87

0.81

5.2

10.5

—

Dental operations

2.34

0.79

9.6

1.2

—

Superficial injury of ankle and foot

1.77

0.76

9.3

7.9

—

Desensitization to allergens

0.00

0.76

0.0

8.6

—

Inflammatory diseases of female pelvic organs

1.84

0.74

2.0

2.6

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.64

0.73

8.9

9.1

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.64

0.73

8.9

9.1

—

Mental retardation, wide definition

1.63

0.73

7.2

9.9

—

Mental retardation

1.62

0.73

7.2

9.9

—

Non-allergic asthma

2.00

0.72

7.0

10.3

—

Infections with a predominantly sexual mode of transmission

2.00

0.72

2.4

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.55

0.69

3.0

7.5

—

Congenital malformations of genital organs

1.70

0.69

9.1

9.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

1.85

0.68

9.6

9.3

—

Leisure time condition

1.85

0.68

7.8

6.1

—

Disorders of eyelid, lacrimal system and orbit

1.51

0.67

4.4

6.0

—

IBD patients in KELA-register

1.79

0.66

8.2

5.5

—

Effects of foreign body entering through natural orifice

1.59

0.65

8.0

6.3

—

Soft tissue disorders

1.35

0.64

7.1

6.8

—

Cardiac arrhythmias

0.57

0.64

8.8

6.0

—

Mood [affective] disorders

1.43

0.63

2.9

5.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.61

0.63

4.1

6.1

—

Use of hypnotics and sedatives

1.48

0.63

1.9

5.5

—

Mood disorders

1.43

0.63

2.9

5.2

—

Other symptoms and signs involving cognitive functions and awareness

1.70

0.62

1.8

3.7

—

False labour

0.00

0.62

0.0

2.5

—

Diseases of liver

1.67

0.61

1.8

4.3

—

Migraine

1.49

0.60

4.2

7.0

—

Depression

1.43

0.59

3.0

5.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.61

0.59

4.0

5.3

—

Triptan medication for migraine, single purchase ok

0.61

0.59

4.0

5.3

—

Other congenital malformations, including avohilmo

1.51

0.58

5.9

9.1

—

Sleep apnoea

0.56

0.58

5.0

3.6

—

Infections specific to the perinatal period

1.67

0.57

11.3

8.7

—

Fracture of foot, except ankle

1.62

0.55

5.2

6.7

—

Disorders of lipoprotein metabolism and other lipidaemias

1.52

0.55

2.9

3.4

—

Injuries to the shoulder and upper arm

0.63

0.55

3.9

5.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.51

0.53

2.8

3.5

—

Injury, poisoning and certain other consequences of external causes

1.42

0.52

6.8

7.9

—

Congenital malformations of cardiac septa

1.43

0.52

6.6

9.7

—

External causes of morbidity and mortality

1.37

0.51

6.2

7.6

—

Type of accident

1.46

0.50

10.3

5.7

—

Cerebrovascular diseases

1.56

0.49

3.6

3.5

—

Sleep disorders

0.63

0.49

3.0

4.6

—

Chronic apical periodontitis

0.67

0.47

1.0

5.2

—

Other antidepressants

1.40

0.47

2.6

3.7

—

Parasetamol

1.38

0.46

3.9

6.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.44

0.46

1.4

6.7

—

Other congenital malformations

1.43

0.46

6.6

9.5

—

Other nutritional deficiencies

1.43

0.45

2.6

5.9

—

Neurological diseases

1.28

0.45

5.6

8.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.68

0.45

2.0

6.5

—

Depression or dysthymia

1.51

0.44

4.1

4.6

—

Chronic lower respiratory diseases

105

1.25

0.43

5.4

6.5

—

Supervision of normal pregnancy

0.00

0.43

0.0

1.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.71

0.42

2.7

5.4

—

Other abnormal products of conception

0.00

0.42

0.0

2.1

—

Inflammatory bowel disease, strict (require KELA)

1.56

0.42

8.2

5.7

—

Liveborn infants according to place of birth

0.00

0.41

0.0

8.4

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.41

0.0

8.1

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.41

0.0

8.7

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.41

0.0

8.1

—

Superficial injury of shoulder and upper arm

0.00

0.41

0.0

5.9

—

Falls/tendency to fall

104

0.77

0.40

5.2

6.7

—

Bitten or struck by other mammals

0.00

0.40

0.0

6.6

—

Insomnia

0.68

0.40

3.0

4.2

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.40

0.0

7.0

—

Asthma (diagnoses ohter than nonallergic)

114

1.27

0.38

5.9

6.5

—

Type 2 diabetes, wide definition

1.51

0.37

1.8

2.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.35

0.37

3.0

7.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.38

0.34

3.7

5.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.31

0.33

2.5

3.5

—

Asthma/COPD (KELA code 203)

103

1.23

0.32

5.6

6.4

—

Pain in joint

1.36

0.31

3.6

7.2

—

Disorders of conjunctiva

113

1.23

0.31

5.3

6.7

—

Dyspnoea

1.28

0.31

3.1

6.7

—

Artificial joint operation, meniscal resection

1.28

0.30

1.1

2.5

—

Focal epilepsy

1.30

0.30

6.7

7.4

—

Conjunctivitis

111

1.23

0.29

5.6

6.8

—

Intracranial injury

100

0.75

0.29

4.3

6.8

—

D07AA Corticosteroids, weak (group I)

1.23

0.29

6.9

8.9

—

Other (not insulin) diabetes medications

1.23

0.27

1.8

2.6

—

Septal defects

1.22

0.27

7.3

9.9

—

Caries of dentine, including avohilmo

1.26

0.26

6.9

8.0

—

Fracture of lower leg, including ankle

0.69

0.26

5.2

5.1

—

Codeine or tramadol medication

1.22

0.26

2.0

1.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.23

0.25

3.4

4.1

—

Diabetes medication

0.79

0.25

1.9

6.4

—

Transport accidents

1.21

0.25

7.0

6.5

—

Asthma, including avohilmo

108

1.17

0.25

5.8

6.5

—

Arthrosis

1.37

0.24

2.8

2.1

—

Shoulder lesions

1.36

0.24

2.2

1.5

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.71

0.24

2.5

7.0

—

Substance abuse, excluding more controls

1.35

0.23

1.2

2.6

—

Ventricular septal defect, a heart condition

1.28

0.23

5.8

10.1

—

Allergic conjunctivitis

0.73

0.22

3.1

7.0

—

Malignant neoplasm of breast, including Hilmo

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.00

0.22

0.0

1.1

—

Premature rupture of membranes

0.00

0.22

0.0

2.0

—

Prolonged pregnancy

0.00

0.21

0.0

2.6

—

AV-block

0.00

0.21

0.0

5.0

—

Presence of cardiac and vascular implants and grafts

0.00

0.21

0.0

1.4

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.21

0.0

9.8

—

Medicines for HER+ breast cancer

0.00

0.21

0.0

1.2

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.21

0.0

11.9

—

Protein-energy malnutrition of moderate and mild degree

0.00

0.21

0.0

10.6

—

Deforming dorsopathies

1.19

0.21

4.6

6.6

—

Gender identity disorders

0.00

0.21

0.0

5.6

—

Major anomalies of jaw size

0.00

0.21

0.0

7.4

—

Exposure to other and unspecified animate mechanical forces

0.00

0.21

0.0

10.5

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

7.9

—

Struck by thrown, projected or falling objec

0.00

0.21

0.0

7.4

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

6.1

—

Injury of unspecified body region

0.00

0.21

0.0

7.5

—

Assault by bodily force

0.00

0.21

0.0

4.9

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

5.2

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

4.8

—

Spondylolisthesis/Spondylolysis

0.00

0.21

0.0

5.0

—

Benign lipomatous neoplasm

0.00

0.21

0.0

3.1

—

Generalized epilepsy, strict definition

0.00

0.21

0.0

9.3

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

9.4

—

Etanercept

0.00

0.21

0.0

9.3

—

Allergic contact dermatitis

0.00

0.21

0.0

6.9

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.21

0.0

2.8

—

Unspecified fall

0.79

0.21

6.3

7.4

—

Contact with other sharp object(s)

0.00

0.21

0.0

8.0

—

Functional dyspepsia

0.00

0.21

0.0

4.4

—

Intracranial trauma

0.80

0.20

3.9

8.1

—

Enterobiasis, including avohilmo

0.00

0.20

0.0

10.3

—

Foreign body in respiratory tract

0.00

0.20

0.0

7.1

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.20

0.0

4.7

—

Superficial injury of hip and thigh

0.00

0.20

0.0

6.2

—

Migraine without aura

1.25

0.20

4.2

6.8

—

Open wound of head

1.21

0.19

6.8

7.2

—

Injuries to the hip and thigh

1.14

0.19

5.0

6.1

—

Hard cardiovascular diseases

0.83

0.18

7.0

6.3

—

Injuries to the ankle and foot

109

1.17

0.18

6.8

6.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.83

0.18

1.8

6.3

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.20

0.18

13.3

9.7

—

Type 2 diabetes, strict (exclude DM1)

1.16

0.18

1.9

2.3

—

Type 2 diabetes, definitions combined

1.16

0.18

1.9

2.3

—

Type 2 diabetes

1.19

0.17

1.8

2.8

—

Appendicitis, broad definition

0.75

0.17

5.4

3.3

—

Diseases of appendix

0.74

0.17

5.4

3.3

—

Other fall from one level to another

0.76

0.17

5.6

8.8

—

Diabetes mellitus

0.84

0.16

2.3

6.6

—

Dermatophytosis, including avohilmo

1.17

0.16

4.0

5.2

—

Haemorrhagic and haematological disorders of fetus and newborn

1.16

0.16

6.4

9.3

—

Gastro-oesophageal reflux disease

1.14

0.16

3.4

6.7

—

Low back pain

1.12

0.16

2.8

4.2

—

Epilepsy

1.14

0.16

6.0

8.4

—

Insulin, intermediate and long-acting

1.13

0.16

1.0

7.0

—

Dental pulpitis, including avohilmo

0.83

0.16

1.8

5.1

—

Diabetes, varying definitions

0.85

0.16

2.3

6.6

—

Obesity

1.11

0.16

2.3

5.7

—

Obesity and other hyperalimentation

1.11

0.16

2.3

5.7

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.10

0.15

1.4

6.8

—

Selective serotonin reuptake inhibitors

1.15

0.13

3.9

5.6

—

Constipation

1.13

0.12

4.4

7.4

—

Congenital malformations of great arteries

1.14

0.10

9.4

10.1

—

Alcohol use disorder, Swedish definition

1.14

0.10

2.0

2.7

—

Focal epilepsy, strict definition

1.06

0.09

6.6

7.6

—

Type 2 diabetes, definitions combined, including avohilmo

1.12

0.08

1.9

2.4

—

Substance abuse

0.81

0.08

1.2

3.6

—

Fracture of shoulder and upper arm

0.82

0.08

5.6

6.9

—

Insulin, fast-acting or short human

1.06

0.08

1.6

7.5

—

Insulin, fast-acting

1.06

0.08

1.6

7.5

—

Hypothyroidism, other/unspecified

1.13

0.07

3.7

4.5

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.86

0.07

6.3

—

Lower back pain or/and sciatica

0.87

0.06

2.6

3.6

—

Other external causes of accidental injury

0.92

0.05

5.3

7.1

—

Other dorsopathies, not elsewhere classified

1.08

0.05

2.9

5.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.11

0.05

3.7

4.4

—

Major coronary heart disease event

0.92

0.04

6.3

6.4

—

Injuries to the elbow and forearm

103

1.08

0.04

7.0

6.1

—

Injuries to the head

112

1.06

0.04

5.2

6.7

—

Emergency coronary revascularization (for ACS)

0.93

0.03

6.3

6.4

—

Episodal and paroxysmal disorders

107

1.04

0.02

4.3

7.3

—

Fall on same level

113

1.04

0.01

5.9

6.5

—

Coronary revascularization (ANGIO or CABG)

0.95

0.01

6.3

6.4

—

Percutaneous Coronary Intervention

0.95

0.01

6.3

6.4

—

Exposure to unspecified factor

118

1.04

0.00

4.4

6.8

—

Dorsopathies

1.04

0.00

5.5

6.1

—

Other specific joint derangements/joint disorders

1.01

0.00

3.8

6.0

—

Disorders of the thyroid gland

1.05

0.00

3.7

4.3

—

Accidents

0.99

0.00

5.1

7.1

—

Ischemic heart diseases

0.99

0.00

5.9

6.4

—

Arthropathies

1.00

0.00

6.7

6.5

—

Dorsalgia

0.98

0.00

3.3

5.4

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

0.00

0.0

4.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.0

1.1

—

Nasal polyp

0.00

0.0

2.4

—

Stenosis and insufficiency of lacrimal passages

0.00

0.0

6.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

3.9

—

Coronary artery bypass grafting

0.00

0.0

1.8

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

7.8

—

0.84

0.00

2.0

3.5

—

Toxic effect of contact with venomous animals

0.00

0.0

8.1

—

0.98

0.00

2.5

3.4

—

Necrosis of pulp, including avohilmo

0.87

0.00

3.8

—

Alopecia areata

0.00

0.0

9.2

—

Lateral epicondylitis

0.00

0.0

1.8

—

Polycystic ovarian syndrome, broad definition

0.00

0.0

1.9

—

Sub-endpoint used in defining T1D endpoints

0.98

0.00

2.5

8.4

—

Open wound of hip and thigh

0.00

0.0

5.3

—

Unspecified/other endometriosis

0.00

0.0

2.2

—

Medical treatment for female infertility

0.00

0.0

1.0

—

L04AC Interleukin inhibitors

0.00

0.0

6.1

—

Seronegative juvenile rheumatoid arthritis

0.00

0.0

9.5

—

Ectopic pregnancy

0.00

0.0

1.0

—

Preterm labour and delivery

0.00

0.0

1.1

—

Other sleep disorders

0.00

0.0

5.0

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

0.0

10.6

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.7

—

Malignant neoplasm of bone and articular cartilage

0.00

0.0

10.0

—

Microcephaly

0.00

-0.00

0.0

6.6

—

Concussion

0.94

-0.00

3.9

8.0

—

Fibroblastic disorders

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

4.8

—

Other perinatal haematological disorders

0.00

-0.00

0.0

8.4

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

10.9

—

Neonatal jaundice from other and unspecified causes

0.89

-0.00

3.2

9.7

—

Heartburn

0.00

-0.00

0.0

3.9

—

0.00

-0.00

0.0

7.6

—

Muscular dystrophy

0.00

-0.00

0.0

8.6

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Superficial injury of neck

0.00

-0.00

0.0

8.7

—

Inflammatory diseases of prostate (prostatitis)

0.00

-0.00

0.0

2.8

—

Other and unspecified injuries of head

0.00

-0.00

0.0

11.0

—

Biguanides

0.93

-0.00

1.7

2.4

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

3.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

3.0

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

5.8

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

9.3

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

6.2

—

Fatigue fracture of vertebra

0.00

-0.00

0.0

10.8

—

Other bursopathies

0.00

-0.00

0.0

3.4

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

8.4

—

Other osteochondrodysplasias, including avohilmo

0.00

-0.00

0.0

8.0

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.8

—

Open wound of forearm

0.00

-0.00

0.0

5.4

—

Contact with sharp glass

0.00

-0.00

0.0

6.7

—

Other disorders of pigmentation

0.00

-0.00

0.0

7.2

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

5.5

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

5.1

—

Perineal laceration during delivery

0.00

-0.00

0.0

3.4

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

5.3

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.0

—

Maxillary prognathism

0.00

-0.00

0.0

8.2

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

3.2

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

3.1

—

Aortic hypoplasia

0.00

-0.00

0.0

6.4

—

Insulin medication

1.00

-0.00

1.4

6.7

—

Flat foot [pes planus] (acquired)

0.00

-0.00

0.0

4.8

—

Dermatitis due to ingested food

0.96

-0.00

6.6

9.1

—

Fall involving bed

0.00

-0.00

0.0

10.0

—

Varicose veins of other sites

0.00

-0.00

0.0

5.4

—

Outcome of delivery

0.00

-0.00

0.0

1.3

—

Postpartum care and examination

0.00

-0.00

0.0

1.4

—

Other and unspecified visual disturbances

0.00

-0.00

0.0

6.0

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

8.2

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

5.7

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Mental disorders, not otherwise specified

0.00

-0.00

0.0

5.7

—

Mental and behavioural disorders due to alcohol

1.01

-0.00

2.0

3.2

—

Maltreatment syndromes

0.00

-0.00

0.0

7.3

—

Optic atrophy

0.00

-0.00

0.0

9.2

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

8.8

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

-0.00

0.0

9.0

—

Primary coxarthrosis, bilateral

0.00

-0.00

0.0

1.7

—

Other inflammation of eyelid, including avohilmo

1.00

-0.00

3.3

5.4

—

Optic atrophy, wide definition

0.00

-0.00

0.0

9.2

—

Disorder of the sleep-wake schedule

0.00

-0.00

0.0

11.4

—

Primary open-angle glaucoma, strict

0.00

-0.00

0.0

1.8

—

FESS (DNB20)

0.00

-0.00

0.0

5.6

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

8.5

—

Fracture of forearm

0.92

-0.00

5.1

6.2

—

Mental and behavioural disorders due to psychoactive substance use

0.98

-0.00

1.8

3.6

—

Ethmoidectomy

0.00

-0.00

0.0

4.8

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

0.00

-0.00

0.0

10.0

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

6.6

—

Primary open-angle glaucoma

0.00

-0.00

0.0

1.8

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

6.5

—

Nontoxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Familial hypercholesterolemia

0.00

-0.00

0.0

6.7

—

Constitutional tall stature

0.00

-0.00

0.0

6.2

—

Visual field defects

0.00

-0.00

0.0

7.6

—

Thyrotoxicosis with diffuse goitre

0.00

-0.00

0.0

3.5

—

Type 1 diabetes

0.95

-0.00

2.5

8.0

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

0.00

-0.00

0.0

8.4

—

Obesity due to excess calories

1.00

-0.00

1.8

6.2

—

Hallux valgus (acquired)

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of breast, HER-positive

0.00

-0.00

0.0

1.1

—

Nontoxic goitre/thyroid nodule

0.00

-0.00

0.0

1.4

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

8.4

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.0

—

Spondylopathies

0.98

-0.00

1.6

3.8

—

Other osteochondrodysplasias

0.00

-0.00

0.0

8.0

—

Down's syndrome

0.00

-0.00

0.0

8.7

—

Ptosis of eyelid

0.00

-0.00

0.0

7.8

—

Impingement syndrome of shoulder

0.00

-0.00

0.0

1.5

—

Ovarian dysfunction

0.00

-0.00

0.0

2.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS